Dr. Sara Sugra Patrawala, MD

Dr. Patrawala practices at Alexander Park Campus - Diabetes and Endocrinology in Rochester, New York.

Dr. Patrawala's NPI, 1821373705, was assigned on October 11, 2011. Dr. Patrawala holds New York license 286726.

Dr. Patrawala's primary practice is Alexander Park Campus - Diabetes and Endocrinology, at 224 Alexander St, Rochester, NY 14607 in Monroe County. The practice phone is (585) 922-8400.

Dr. Patrawala's primary practice is Alexander Park Campus - Diabetes and Endocrinology in Rochester, New York. Dr. Patrawala is also affiliated with Strong Memorial Hospital. The medical group on file is Rochester General Hospital. Dmand AI also links Dr. Patrawala to 1 more hospital and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Patrawala practices, 2 sites in all. Vendor and product names are available with a free account.

Allergy and immunology is Dr. Patrawala's primary specialty in the NPI Registry, under taxonomy code 207K00000X. Dmand AI has Dr. Patrawala's licenses on file in 2 states: New York and Michigan.

CMS data shows 40 Medicare services from Dr. Patrawala across 2 procedure codes in 2024, all of them office visits, for 54 Medicare patients. Medicare paid $3,398 for them. Every service was in an office.

CMS counts 54 Medicare patients who saw Dr. Patrawala in 2024. The largest group is 65 to 74, with 26 patients. 75% of them have high cholesterol, and 67% have high blood pressure. 48% are also on Medicaid. Their average risk score is 1.66, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Patrawala's median patient age at 40, with 67% women.

In 2024, Dr. Patrawala wrote 295 Medicare Part D claims for 101 patients. 71% of them were for generic drugs. CMS names the drug for 179 of them, across 10 drugs with 11 or more claims each, at $22,487 in total drug cost. In 2023, CMS named 82 claims across 5 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 97 out of 100 for Dr. Patrawala for performance year 2024, reported through an alternative payment model (APM). Dr. Patrawala accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 7 papers to Dr. Patrawala, published from 2021 to 2025. 2022 was the busiest year, with 2. The most frequent topics are Allergens and Skin Tests. Dr. Patrawala has published most often in Ann Allergy Asthma Immunol. Dr. Patrawala's most frequent co-authors are Allison Clare Ramsey, MD, Peter Capucilli, MD and Jonathan Wade Bress, MD.

CMS Open Payments shows 62 general payments to Dr. Patrawala from 18 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 48% of the total. Pharming Healthcare, Inc. paid the most, $2,304.